Royal Melbourne Hospital | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD	Chronic Disease, Death, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, heart disorder, heart failure, kidney disorder, kidney failure, urinary system disorder	Active, not recruiting	Phase 3	2026-10-08		NCT05374291
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, respiratory system disorder	Recruiting	Phase 2 / Phase 3	2026-05-11		NCT04310930
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).	Digestive System Diseases, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic esophagitis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder	Recruiting	Phase 1 / Phase 2	2026-03-19		NCT05608681
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease	Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy	Recruiting	Phase 1	2025-05-06		NCT06732180